INTERSTITIAL LUNG DISEASE
Clinical trials for INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New inhaled treatment shows promise for scarred lungs in major trial
Disease control CompletedThis study tested an inhaled medication called treprostinil in 598 adults with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs and makes breathing hard. The goal was to see if the drug could slow the decline in lung function over one year compared to a placebo…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 26, 2026 10:30 UTC
-
Can a lung drug help COVID survivors breathe easier?
Disease control CompletedThis study tested whether the drug nintedanib can slow lung scarring in people who had COVID-19 and still have lung problems more than 30 days later. 103 adults who needed oxygen or had low oxygen levels took part. The goal was to see if the drug helps preserve lung function over…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Inhaled drug shows promise for exercise in lung disease patients
Disease control CompletedThis study looked at how an inhaled medication called treprostinil affects exercise ability in people with pulmonary hypertension caused by interstitial lung disease. 29 participants took the drug for 3 months. Researchers measured heart function and breathing efficiency during e…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New hope for sarcoidosis patients: inhaled drug targets lung and heart strain
Disease control CompletedThis study tested an inhaled medication called treprostinil in 5 people with sarcoidosis who also have lung scarring and high blood pressure in the lungs. The goal was to see if the drug could improve blood flow and heart function. Participants took the drug and were monitored wi…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Can a chemo drug save lungs in scleroderma patients?
Disease control CompletedThis study tested whether adding a strong immune-suppressing drug (cyclophosphamide) to standard prednisone can stop lung function from getting worse in people with scleroderma-related lung scarring. Forty adults with worsening lung function took part. The goal was to see if more…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Inhaled drug shows safety in long-term use for rare lung-heart condition
Disease control CompletedThis study checked the long-term safety of an inhaled powder drug (treprostinil palmitil) in 31 people with pulmonary hypertension caused by interstitial lung disease. Participants had already completed a previous study of the same drug. The main goal was to see how many had side…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated May 04, 2026 16:32 UTC
-
Walking your way to better breathing: exercise study for pulmonary hypertension
Symptom relief CompletedThis study looked at whether a 10-week aerobic exercise program can help people with pulmonary hypertension (high blood pressure in the lungs) walk farther and feel better. About 97 adults aged 21 to 82 took part, with some starting exercise right away and others waiting 10 weeks…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Symptom relief
Last updated May 19, 2026 12:01 UTC
-
Simple breathing device shows promise for lung disease fatigue
Symptom relief CompletedThis study tested whether a lung boost exercise device could improve breathing and reduce fatigue in 40 women with interstitial lung disease (ILD). Participants used the device and had their lung function, oxygen levels, and tiredness measured before and after treatment. The goal…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
Ultrasound vs. blood test: which better spots lung trouble in ICU?
Knowledge-focused CompletedThis study looked at 86 ICU patients with a lung condition called interstitial syndrome. Researchers wanted to see if a lung ultrasound score (LUSS) could accurately measure how severe the condition is, compared to a standard blood oxygen test (PaO2/FiO2). They checked both at th…
Matched conditions: INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Knowledge-focused
Last updated May 26, 2026 10:25 UTC
-
Can a smartphone app help manage chronic disease? study finds out.
Knowledge-focused CompletedThis study tested how easy and acceptable the P-STEP mobile app is for people with chronic conditions like asthma, COPD, heart disease, or type 2 diabetes. 178 adults in Leicester, UK, used the app for 12 weeks and gave feedback on its usability. The goal was to see if the app is…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: University of Leicester • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC
-
Stomach acid in lungs? new study links hiatal hernia to hidden lung scarring
Knowledge-focused CompletedThis study looked at whether a hiatal hernia (a condition where part of the stomach pushes into the chest) might cause tiny, unnoticed lung damage that could lead to scarring over time. Researchers measured stomach contents like pepsin in the lung fluid of 14 adults—some with a h…
Matched conditions: INTERSTITIAL LUNG DISEASE
Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC